AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

DYNAVAX TECHNOLOGIES CORP Director's Dealing 2013

Jul 11, 2013

Director's Dealing

Opens in your device viewer

Issuer: DYNAVAX TECHNOLOGIES CORP (DVAX)
CIK: 0001029142
Period of Report: 2013-07-09

Reporting Person: Janssen Robert (Chief Medical Officer and VP)

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2013-07-09	Restricted Stock Unit	$1.16	A	150000	Acquired	2023-07-08	Common Stock (150000)	Direct

F1: These restricted stock units shall vest upon achievement of certain performance conditions.

F2: Not applicable.